Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma

YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE
Anticancer Research May 2024, 44 (5) 2081-2089; DOI: https://doi.org/10.21873/anticanres.17012
YOUNG WHA KOH
1Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: youngwha9556@gmail.com
JAE-HO HAN
1Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEOKJIN HAAM
2Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYUN WOO LEE
3Department of Hematology-Oncology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 5 2081-2089
DOI 
https://doi.org/10.21873/anticanres.17012
PubMed 
38677736

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 11, 2024
  • Revision received March 14, 2024
  • Accepted March 19, 2024
  • Published online April 27, 2024.

Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. YOUNG WHA KOH1⇑,
  2. JAE-HO HAN1,
  3. SEOKJIN HAAM2 and
  4. HYUN WOO LEE3
  1. 1Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea;
  2. 2Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea
  3. 3Department of Hematology-Oncology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea
  1. Correspondence to: Young Wha Koh, MD, Ph.D., Associate Professor, Department of Pathology, Ajou University School of Medicine, 206 Worldcup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do 16499, Republic of Korea. Tel: +82 312197055, Fax: +82 312195934, e-mail: youngwha9556{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment
    Junyu Qiu, Zilin Cheng, Zheng Jiang, Luhan Gan, Zixuan Zhang, Zhenzhen Xie
    International Journal of Molecular Sciences 2024 25 10
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (5)
Anticancer Research
Vol. 44, Issue 5
May 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM, HYUN WOO LEE
Anticancer Research May 2024, 44 (5) 2081-2089; DOI: 10.21873/anticanres.17012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM, HYUN WOO LEE
Anticancer Research May 2024, 44 (5) 2081-2089; DOI: 10.21873/anticanres.17012
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
  • Google Scholar

More in this TOC Section

  • Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
  • Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
  • Corrigendum
Show more Clinical Studies

Similar Articles

Keywords

  • Lung squamous cell carcinoma
  • Lung adenocarcinoma
  • PD-L1
  • PD-1
  • miRNA
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire